Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder.

Targum SD, Wedel PC, Fava M. Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder. J Psychiatr Res. 2015 Sep; 68:392-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.